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cardiac remodeling process. Recently we found that there is the signaling pathway of
dual speciﬁcity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulate the
alternative splicing of CaMK IId through alternative splicing factor (ASF). Here we
aimed to investigate the possible involvement of CaMK IId-dependent signaling in
renovascular hypertension-induced cardiac hypertrophy, and further explore the
complex mechanisms by which valsartan, an angiotensin receptor blocker, inhibited
the cardiac hypertrophy.
Methods: Renovascular hypertension was induced by two-kidney one-clip (2K1C).
Dyrk1A and ASF protein expression were measured by western blotting, and real-time
PCR was used to determine the alternative splicing of CaMK IId.
Results: After two-kidney one-clip (2K1C), rats were treated with valsartan
(30 mg/kg per day) for 8 weeks; hypertrophic parameter analysis showed that val-
sartan attenuated cardiac hypertrophy in renovascular hypertensive rats. Western blot
analysis showed that valsartan signiﬁcantly attenuated 2K1C-induced increase in the
truncated expression of Dyrk1A, while signiﬁcantly reversed 2K1C-induced nuclear
speckle transportion of ASF in renovascular hypertensive rats. RT-PCR demonstrated
that valsartan adjusted 2K1C-induced imbalance in alternative splicing of CaMK IId
by up-regulating the mRNA expression of CaMK IIdC and down-regulating the
mRNA expression of CaMK IIdA and CaMK IIdB.
Conclusions: The results suggested that valsartan inhibition of cardiac hypertrophy in
renovascular hypertensive rats might be at least partly mediated by Dyrk1A/ASF-
regulated alternative slicing of CaMK IId.
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Objectives: Myricetin (Myr) is a ﬂavonoid. The previous studies reported that Myr
had antiarrhythmic effect. The potential ionic mechanisms are, however, not under-
stood. The present study was designed to investigate the effect of Myr on Kv1.5
channel expressed in HEK 293 cells using a whole-cell patch voltage-clamp technique
and western blotting.
Methods:We recorded the current of Kv1.5 expressed in HEK 293 cells with a whole-
cell patch voltage-clamp technique, Kv1.5 protein was detected by western blotting
after 24-hour treatment of Myr.
Results: Myr reduced Ikur from 211.040748.37848 (pA/pF) to 57.0543317.75726
(pA/pF) (n¼9, P¼0.013<0.05, VS Control) in a dose-dependent manner. Current
suppression ratio (0.31010.1234) increased to (0.54970.1060) under the effect of
Myr from 5 min to 20 min. Ikur was 897.2023967.41077, 906.7886572.96036,
840.0394272.4424 and 828.3304574.39913 at 0.5, 1, 3, 4Hz, respectively.
Moreover, Myr inhibited h Kv1.5 protein in a dose-dependent manner.
Conclusions: We have demonstrated that Myr inhibit Ikur and its protein in hKv1.5
expressed of HEK 293 cell, which was dose-, use- and frequency-dependent. In
addition, which may partly explains the mechanism of Myr lowering heart rate.
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Objectives: The purpose of this study was to explore molecular mechanisms under-
lying the d-sotalol hydrochloride-induced QT prolongation associated with a com-
pound mutation L539fs/47.
Methods: The L539fs/47-hERG plasmids were transfected into the HEK293 cells
stably expressing WT-hERG channels to simulate heterozygous mutant (WT+L539fs/
47-hERG). Whole cell patch-clamp technique were used to measure hERG currents in
the control condition and exposed to d-sotalol hydrochloride. Additionally, laser
confocal scanning microscopy was used to evaluate the membrane distribution of
hERG channel protein using a green ﬂuorescent protein tagged to the N-terminus of
hERG.
Results: D-sotalol hydrochloride caused inhibition of WT-hERG and heterozygous
L539fs/47-hERG currents in HEK293 cells. However, the effect was more signiﬁcant
in the cells expressing heterozygous L539fs/47-hERG channels. The maximal density
of tail currents in cells expressing WT-hERG channels and heterozygous L539fs/
47-hERG channels exposed to d-sotalol hydrochloride were 34.712.9 pA/pF and
8.891.3pA/pF, which corresponded to a decrease compared with values from cells
expressing WT-hERG 46.973.65 pA/pF and heterozygous L539fs/47-hERG
16.572.0 under the control condition, respectively. D-sotalol hydrochloride showed
46.35% inhibition effect on heterozygous L539fs/47-hERG and 26.10% inhibition
effect on WT-hERG. Additionally, L539fs/47-hERG also altered the potential of
d-sotalol hydrochloride on the kinetics of activation, inactivation, recovery from
inactivation and deactivation. In the molecular biological experiments, we found that
d-sotalol hydrochloride also caused a reduction of hERG channel protein expressionC40 JACC Vol 64/16/Suppl C j Octobon the cell membrane and resulted in retention in the endoplasmic reticulum. How-
ever, the reduction and retention was much more serious in the cells expressing
heterozygous L539fs/47-hERG compared to the cells expressing WT-hERG.
Conclusions: The compound mutation L539fs/47-hERG obviously enhanced the
susceptibility of hERG channels to d-sotalol hydrochloride. This may explain the
drug-induced LQTS and TdP related symptoms during the administration of sotalol.
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Objectives: It has been previously reported that the activation of G-protein coupled
estrogen receptor (GPER) can alleviate the maladaptive ventricular hypertrophy and
ﬁbrosis that develops in mice after experimental cardiac infarction.
Methods: Our present studies, performed on cultures of human cardiac ﬁbroblasts
investigated whether such beneﬁcial effects of this receptor would be exercised
through the mechanisms interfering with deposition of major components of extra-
cellular matrix; elastin and collagen.
Results: We found that treatment with 10-7 to 10-5 mol/L G1 (agonist of the GPER)
not only resulted with a signiﬁcant inhibition of collagen deposition, but also
enhanced production of new elastic ﬁbers. Knockdown of GPER using short hairpin
RNAs (shRNAs) signiﬁcantly reduced this effects of G1. Interestingly, we further
demonstrated that the pro-elastogenic effect occurs after the selective activation of
GPER subsequent initiates the downstream PKA/CREB phosphorylation pathway.
PKA knockdown using shRNAs signiﬁcantly blocked CREB subunit phosphorylation
at Ser-133 and abolished the GPER-mediated expression of elastin. We also
demonstrated that G1-induces phosphorylation of CREB contributed to suppression of
collagen I synthesis by phosph-CREB-mediated competition for the transcriptional
activator CBP1 to Smad transcriptional complexes contributing to collagen I gene
transcription.
Conclusions: In summary, our data validate a novel mechanisms in which both anti-
collagenogenic and pro-elastogenic effects occurs after the selective activation of
GPER further initiated the PKA/CREB pathway, induces a crucial balance between
collagenous and elastic ﬁbers that would allow for the best possible resiliency of the
post-infarct scars and the optimal cardiac function.
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Objectives: The ApoE knockout mice progression of atherosclerosis in different time
points, to explore different diet of ApoE knockout mice to progression of
atherosclerosis.
Methods: 8 weeks of age 40 ApoE gene defects in mice, only 20 is given only to a
high-fat diet, 20 gives ordinary diet, respectively from 8, 12, 16, 20, 24-week-old
anesthesia executed 5 points each time 4 lipid and the pathological examination,
determination of serum triglyceride (TG), total cholesterol (TC), high-density
lipoprotein (HDL-c), low density lipoprotein (LDL-c) content, frozen section method
line aortic dyeing, oil red O staining observation atherosclerotic aorta plaque formation.
Results: 16weeks of ApoE knockoutmice on a high-fat diet group in serum triglyceride
levels: 2.200.47 mmol/L (P<0.05), total cholesterol: 17.91.08 mmol/L (P<0.01)
and low density lipoprotein level: 4.320.89 mmol/L (P<0.01), blood lipid level three
group was obviously higher than that of normal mice, high-density lipoprotein
cholesterol (HDL-c) levels in high-fat diet group was obviously lower than normal mice
groups, the tendency for 0.173.65 mmol/L (P<0.01), ApoE knockout mice of
atherosclerotic plaque area (29.2010.38) % was signiﬁcantly higher than the normal
mice (3.61%1.04) %, (P<0.01), along with the age growth and associated with sig-
niﬁcant difference. With the time progress of given different diet, ApoE knockout mice
gradually aggravate the extent of atherosclerosis, a high-fat diet group than normal diet
group of ApoE knockout mice serious pathological changes of atherosclerosis. The
aortic root in 16 weeks of ApoE knockout mice visible lipid plaques.
Conclusions: ApoE knockout mice fed on high-fat diets, the formation of fatty streaks
and ﬁber growths of time faster than normal mice group. So the ApoE knockout mice
is the most advantageous tool in atherosclerosis research ﬁeld.
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Objectives: Orai3 is a store-operated Ca2+ channel speciﬁc for mammals. Previous
studies found that 2-APB, an agonist of Orai3 channel, can either cause or prevent
atrial ﬁbrillation in animals. The aim of this study is to determine whether Orai3
mutation is a pathogenetic factor of atrial ﬁbrillation.
Methods: Genomic DNA was extracted from the peripheral blood of 124 patients
with atrial ﬁbrillation. The two exons of Orai3 gene were separately ampliﬁed from
the genomic DNA and sequenced with corresponding primers. The coding sequences
were assembled and aligned with the reference sequence from GenBank. Mutation
found in the alignment was conﬁrmed by manual check on the original sequencing
chromatograms.
Results: Two of the 124 patients were found to carry heterogenic mutation from C to
T at position 711 of the nucleic acid sequence. However, this mutation does not lead to
any change on translated amino acid sequence.
Conclusions: Due to the lack of non-synonymous mutation in Orai3 gene, we
conclude that Orai3 channel is probably not directly involved in the cardiac action
potential. The effect of 2-APB on atrial ﬁbrillation is more likely related to other
targets of this drug, such as IP3 receptors.
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Objectives: To identify gene mutations of potassium channels that contributed to the
pathogenesis of atrial ﬁbrillation.
Methods: Genomic DNA was extracted from the peripheral blood of 124 patients
with atrial ﬁbrillation. The coding regions of genes including KCNE1 (minK),
KCNE1L (KCNE5), KCNE2 (MiRP1), KCNE4 (MiRP3), KCNJ2 (Kir2.1) and
KCNJ4 (Kir2.3) were ampliﬁed from the genomic DNA and sequenced with corre-
sponding primers. The obtained sequences were aligned with reference sequences
from GenBank. Mutations found in the alignments were conﬁrmed by manual check
on the original sequencing chromatograms.
Results: Mutations leading to changes of amino acids and corresponding mutation
rates were found: KCNE1, S37R (0.8%), S38G (92.7%), D85N (0.8%); KCNE1L,
Y81H (0.16%); KCNE2, none; KCNE4, M109V (0.8%), D196E (91.1%); KCNJ2,
V93I (0.8%); KCNJ4, none.
Conclusions: Genetic mutations on potassium channels are important pathogenetic
factors of atrial ﬁbrillation. Among the six genes screened KCNE1 and KCNE4
showed highest mutation rates. The electrophysiological functionality of these mutants
needs to be examined in the future to understand their impacts to the cardiac action
potential.
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Objectives: To determine the effects of DS-201 on electrical remodeling of canine
and cell membrane potassium ion channels.
Methods: Mongol canines were used for preparation of animal models with AF
through rapid pacing left atrial appendage, and then the effect of DS-201 on AF was
determined by frequency and duration of AF. And Kv1.5 protein expression in atrial
myocytes was detected with western blotting.
Results: It was showed that DS-201 signiﬁcantly reduced both the frequency and
duration of AF (P<0.05, n¼5). The frequency of AF was reduced from 7.21.31 to
3.121.05, and the duration of AF was lowered from 5.22.13 s to 0.891.23 s. It is
interested that DS-201 did not inhibit Kv1.5 protein expression but signiﬁcantly in-
crease its expression.
Conclusions: DS-201 improves tachycardia-induced electrical remodeling of canine
by meliorating the low-level expression of Kv1.5 in AF.
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Objectives: Sodium tanshinone IIA sulfonate (STS) is a water-soluble derivative of
tanshinone IIA, the major lipophilic component extracted from the root of Danshen
(Salvia Miltiorrhiza). STS is clinically used in the treatment of myocardial infarction,
coronary artery disease and other cardiovascular disorders. STS can protect the heart
against pathological hypertrophy in laboratory animals. However, the direct molecular
targets of STS on cardiomyocytes are still unclear. Here we aim to examine the effect
of STS on the activity of TRPC channels, which have been suggested to be important
mediators of pathological cardiac hypertrophy.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BMethods: Intracellular Ca2+ measurement and patch clamp recordings were per-
formed on HEK293 cells stably transfected with human TRPC4 and TRPC5 cDNA.
STS was applied to the extracellular solution to test the drug effect.
Results: We found that STS at micromolar concentrations inhibited TRPC4 and
TRPC5 channels. The potency of tanshinone IIA on the inhibition of these channels is
much lower than that of STS, suggesting the sulfonation of this compound is
important for its channel-inhibitory activity.
Conclusions: The inhibition of TRPC channels by STS found in this study is a novel
aspect of the cardioprotective pharmacology of this drug. As STS has been used in
patients by injection with safety approval, our results suggest that blockade of TRPC
channels is a potentially safe strategy for clinical therapy.
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Objectives: The objective of this study was to investigate whether monoclonal
autoantibodies against the second extracellular loop of b1-adrenergic receptor (b1-AR
mAb) induce directly ventricular arrhythmias and to clarify the electrophysiologic
mechanisms.
Methods: To identify the function of b1-AR mAb, the binding of b1-AR mAb with
the b1-adrenergic receptor (b1-AR) on the H9C2 by laser scanning confocal micro-
scopy and the effects of b1-AR mAb on the beat frequency in cultured ventricular
myocytes of neonatal rats were observed. A langendorff perfused heart model was
used in this study to explore the direct roles of b1-AR mAb in arrhythmias.
Results: Results showed that b1-AR mAb may bind with b1-AR and increase the beat
frequency of ventricular myocytes of neonatal rats, which was similar to autoanti-
bodies against the second extracellular loop of b1-adrenergic receptor (b1-AA) isolated
from patients, thus b1-AR mAb might be seen as the tool to stuy b1-AA. b1-AR mAb
induced ventricular premature contractions, and enhanced the excitability of ventric-
ular ﬁbrillation by decreasing the threshold of ventricular ﬁbrillation (b1-AR mAb
group: 9.01.5 V; Control group: 11.02.1 V, P<0.05, n¼5/group) and prolonging
the duration of ventricular ﬁbrillation (b1-AR mAb group: 1608.0135.0 ms; Control
group: 1000.0127.1 ms, P<0.05, n¼5/group); b1-AR mAb increased the suscepti-
bility to ventricular arrhythmias as a result of repolarization abnormalities by reducing
corrected QT intervals (0 min: 360.011.1 ms; 10 min: 333.014.0 ms, P<0.05,
n¼5/group) and prolonging late phase repolarization of monophasic action (MAPD90-30)
(0 min: 360.011.1 ms; 10 min: 333.014.0 ms, P<0.05, n¼5/group) in isolated
guinea pig hearts.
Conclusions: It is concluded that b1-AR mAb could induce directly ventricular
arrhythmias attributed to the increase of the susceptibility of ventricular arrhythmias
by causing repolarization abnormalities.
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Objectives: The aim of this study was to evaluate the cardioprotective effect of
pinacidil postconditioning on rat hearts with transient hypoxia and reperfusion.
Methods: An acute myocardial anoxia-reperfusion rat model was created by ligating
coronary arteries for 10 min and subsequent reperfusion for 60 min. Twenty-four rats
in 4 groups received different treatments: normal hearts as control (N¼6), anoxia-
reperfusion (A/R) only (N¼6), pinacidil postconditioning (N¼6), and pinacidil plus
adenosine triphosphate-sensitive potassium channel inhibitors (glibenclamide) (N¼6).
The kinetic parameters and electrophysiological properties, including early apoptosis
protein expression changes of Bax, Bcl-2, and FN were examined using the isolated
perfusion and patch-clamp technique and immunohistochemistry.
Results: The left ventricular systolic pressure and maximum -dp/dt in A/R groups
were signiﬁcantly higher than those in the control group (P<0.05). The left ventricular
developing pressure, maximum +dp/dt, and heart rate in the A/R group were slightly
decreased. The pinacidil-postconditioned group has better cardiac function recovery
after ischemia/reperfusion than the A/R group (P<0.01). In addition, using the patch-
clamp technique, signiﬁcant differences in the mean open time and conductance value
were found in the pinacidil group relative to the A/R group. The expression of
apoptosis proteins (Bax, FN) increased during A/R, while the Bcl-2 protein expression
decreased. A signiﬁcant difference was found in the pinacidil treatment group relative
to the A/R group.
Conclusions: Pinacidil postconditioning can exert cardioprotective effects on
A/R-injured rat hearts, which may indicate a potential application of pinacidil post-
conditioning to protect A/R-injured hearts.asic and Translational Medicine C41
